Vernalis selects IDBS' E-WorkBook for chemistry as part of company-wide ELN deployment

Guildford, UK, May 19, 2009 - IDBS, the global provider of research informatics solutions, is proud to announce that Vernalis (Cambridge UKLSE:VER), has purchased E-WorkBook Suite for chemistry (ChemBook) as its corporate chemistry data management solution.

Vernalis sought an application that would provide its scientists with state-of-the-art chemistry technologies as well as offering rapid and complete access to all its chemistry and IP related data. ChemBook - a chemistry-specific extension to IDBS' enterprise class E-WorkBook Suite - incorporates IDBS' advanced chemistry technologies by offering a chemically 'aware' spreadsheet for data analysis and statistical trending. The decision to select the E-WorkBook Suite was based on the product's ability to adapt to specific workflows, achieved through configuration - as opposed to customization - of the solution.

Jo Lerpiniere, Senior Informatics Scientist for Vernalis commented: "We were unanimous in choosing the E-WorkBook Suite as our data management solution. IDBS impressed us over its competitors as the E-WorkBook Suite could be configured to meet our needs." The E-WorkBook Suite manages multiple process workflows within and between groups. Flexible and searchable reports are generated across all data stored within the notebook, including file and spectral annotations.

Jo Lerpiniere continued: "IDBS were willing and helpful in demonstrating solutions to streamline our workflow and our aim is to replace all paper based lab notebooks with their ELN. The E-WorkBook Suite is a practical and adaptable choice of ELN that easily integrates with our workflow."

Neil Kipling, founder and CEO of IDBS commented: "We are delighted to be working with Vernalis and providing E-WorkBook Suite to meet their current and future research data management requirements. Vernalis' decision to invest in, and deploy, our solution in their chemistry area is a clear recognition that ChemBook is an influential product in this market. IDBS' ongoing investment in chemistry and data management technologies will continue to keep our products at the forefront of research informatics."

About Vernalis

Vernalis (LSE:VER) is an R&D-based speciality biopharmaceutical company with one marketed product, Frova® and a development pipeline focused on neurology and pain management. The company has six products in clinical development and collaborations with leading, global pharmaceutical companies including Novartis, Biogen Idec, and Servier.

About IDBS

IDBS is a trusted provider of integrated data management software and service solutions to both the life science and non-life science industries. The company's ActivityBase and E-WorkBook Suites provide gold standard chemistry and biology data support from target validation to GxP validated phases of the R&D process. The company supports long term relationships with the leading research organizations, maximizing the value of research data by enabling the capture, storage, sharing and use of data, while protecting intellectual property across the spectrum of research activities.

Headquartered in Guildford, UK, IDBS has worldwide coverage, with U.S. offices in California, New Jersey and Massachusetts, consultancy teams across Europe and a network which delivers IDBS products and advisory services across Asia. Founded in 1989, IDBS employs more than 170 people worldwide.